Imugene Limited Stock Today
| IUGNF Stock | USD 0.06 0.01 16.00% |
Performance0 of 100
| Odds Of DistressOver 67
|
Imugene is trading at 0.058 as of the 23rd of April 2024. This is a 16.00% increase since the beginning of the trading day. The stock's lowest day price was 0.0432. Imugene has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Imugene Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of May 2022 and ending today, the 23rd of April 2024. Click here to learn more.
Imugene Limited, a clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumors in Australia. Imugene Limited was incorporated in 1986 and is based in Sydney, Australia. The company has 6.42 B outstanding shares. More on Imugene Limited
Moving together with Imugene Pink Sheet
| 0.65 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
| 0.64 | REGN | Regeneron Pharmaceuticals Financial Report 2nd of May 2024 | PairCorr |
Moving against Imugene Pink Sheet
| 0.59 | SGEN | Seagen Inc Earnings Call This Week | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Imugene Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Imugene's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Imugene or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO, Managing Director | Leslie Chong |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Imugene Limited [IUGNF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Small-Cap' category with a current market capitalization of 642.17 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Imugene's market, we take the total number of its shares issued and multiply it by Imugene's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Imugene Limited classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 6.42 B outstanding shares.
Imugene Limited has accumulated about 99.89 M in cash with (30.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check Imugene Probability Of Bankruptcy
Ownership AllocationImugene secures a total of 6.42 Billion outstanding shares. Imugene retains 15.4 (percent) of its outstanding shares held by insiders and 8.67 (percent) owned by outside corporations. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Imugene Ownership Details
Imugene Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Imugene jumping above the current price in 90 days from now is about 98.0%. The Imugene Limited probability density function shows the probability of Imugene pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Imugene has a beta of 0.896. This usually indicates Imugene Limited market returns are reactive to returns on the market. As the market goes up or down, Imugene is expected to follow. Additionally, imugene Limited has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Imugene to move above the current price in 90 days from now is about 98.0 (This Imugene Limited probability density function shows the probability of Imugene Pink Sheet to fall within a particular range of prices over 90 days) .
Imugene Limited Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Imugene market risk premium is the additional return an investor will receive from holding Imugene long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Imugene. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Imugene's alpha and beta are two of the key measurements used to evaluate Imugene's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.37 | |||
| Standard Deviation | 6.74 | |||
| Variance | 45.42 | |||
| Risk Adjusted Performance | (0.04) |
Imugene Stock Against Markets
Picking the right benchmark for Imugene pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Imugene pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Imugene is critical whether you are bullish or bearish towards Imugene Limited at a given time. Please also check how Imugene's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Imugene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
Imugene Corporate Management
Elected by the shareholders, the Imugene's board of directors comprises two types of representatives: Imugene inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Imugene. The board's role is to monitor Imugene's management team and ensure that shareholders' interests are well served. Imugene's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Imugene's outside directors are responsible for providing unbiased perspectives on the board's policies.
| BA ASiA | Ex Chairman | Profile | |
| Anthony Good | VP Research | Profile | |
| Nathan CA | Joint Sec | Profile | |
| Ursula Wiedermann | Chief Scientific Officer | Profile | |
| PharmD MBA | Chief Officer | Profile |
How to buy Imugene Pink Sheet?
Before investing in Imugene, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Imugene. To buy Imugene stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Imugene. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Imugene stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Imugene Limited stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Imugene Limited stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Imugene Limited, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Imugene Limited?
The danger of trading Imugene Limited is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Imugene is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Imugene. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Imugene Limited is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imugene Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Complementary Tools for Imugene Pink Sheet analysis
When running Imugene's price analysis, check to measure Imugene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imugene is operating at the current time. Most of Imugene's value examination focuses on studying past and present price action to predict the probability of Imugene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imugene's price. Additionally, you may evaluate how the addition of Imugene to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |